NCT07268859Recruiting
Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea
Effect of Fan Application in Preventing Ticagrelor-associated Dyspnea in Patients With Acute Coronary Syndrome.
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital. It aims to investigate the effect of hand fan therapy on ticagrelor-associated dyspnea in patients receiving ticagrelor.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 18 Jun 2025
- Start date
- 15 Mar 2025
- Primary completion date
- 10 Jan 2026
- Lead sponsor
- Acibadem University
- Diseases
- Coronary artery disease
- NCT number
- NCT07268859
What you commit to
- Study type: Interventional
- Planned participants: 110
- From 15 Mar 2025 to the primary completion date, 10 Jan 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously treated with ticagrelor,
Other illness
- Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
- Individuals with life-threatening conditions
Other
- Having any problem that prevents you from communicating cognitively, emotionally and verbally,
- Obstructive sleep abnormalities,
- With metabolic abnormalities,
- Intubated after the procedure,
- Individuals who did not volunteer to participate in the study. Losses to follow up
- Individuals who wish to leave the study voluntarily.
- Saturation value below 95%,
- The one with the arrest,
- Who will not be able to fulfill the requirements of the work,
Who the study is looking for
- Between the ages of 18 and 65,
- No severe hearing and vision problems,
- Can speak and understand Turkish,
- Easy to communicate with,
- First-time sufferer of acute coronary syndrome (ACS) for the first time,
- Decided to start ticagrelor therapy,
- Able to adapt to treatment,
- Individuals who volunteered to participate in the research.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sağlık Bilimleri Üniversitesi Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
| İstanbul Üniversitesi-Cerrahapaşa Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.